Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-31

Clinical Trial Update: Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety [Phase 2]

View source ↗

Summary

Phase 2 study of chidamide for advanced adenoid cystic carcinoma of the head and neck to assess efficacy and safety; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chidamide (chidamide)

Snippet

Sponsor: Dong mei | Conditions: Adenocystic Carcinoma | Phase 2 | Status: UNKNOWN